Condition 1: Skin aging. Condition 2: Atrophic scar. Atrophic disorder of skin Scar conditions and fibrosis of skin
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: A patient with moderate and severe acne scars Complete consent of the patient to participate in the plan.
Exclusion criteria
Exclusion criteria: malignancy Receiving chemotherapy in the last 5 years Sepsis Smoking Pregnancy or breastfeeding Active wound or infection at the treatment site Receiving any topical or systemic medication in the last 3 months for acne scars
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of wrinkles. Timepoint: Before treatment and six months after the start of treatment. Method of measurement: Visio face.;Scar size. Timepoint: Before treatment and six months after the start of treatment. Method of measurement: Visio face. | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammation. Timepoint: After each session. Method of measurement: Questionnaire and visit.;Intensity of pain. Timepoint: Treatment time. Method of measurement: Questionnaire and visit.;Side effects. Timepoint: One week after treatment. Method of measurement: Questionnaire and visit.;Patient Satisfaction. Timepoint: Three month after treatment. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Skin and Stem cell Research Center of Tehran University of Medical Sciences